Jeff Yass’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166K Buy
85,300
+73,000
+593% +$149K ﹤0.01% 12121
2026
Q1
$29.6K Buy
+12,300
New +$27.5K ﹤0.01% 12767
2025
Q4
Sell
-10,200
Closed -$31.1K 13082
2025
Q3
$31.1K Sell
10,200
-281,200
-96% -$877K ﹤0.01% 11973
2025
Q2
$734K Buy
291,400
+216,500
+289% +$518K ﹤0.01% 8233
2025
Q1
$113K Buy
+74,900
New +$132K ﹤0.01% 11457
2024
Q1
Sell
-10,000
Closed -$16.4K 12853
2023
Q4
$16.4K Sell
10,000
-1,100
-10% -$1.47K ﹤0.01% 12004
2023
Q3
$15.4K Buy
+11,100
New +$24.1K ﹤0.01% 11659

Other funds holding MBOT

Jeff Yass's MBOT Position: Q2 2026 in Review

Jeff Yass reduced its Microbot Medical (MBOT) stake by 43% in Q2 2026, selling an estimated $812K and leaving 525,827 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #8134.

Jeff Yass first reported a position in MBOT in Q3 2014 and has held it in 11 quarters since. The position peaked at $3.81M in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Jeff Yass held 525,827 shares of Microbot Medical worth $1.03M as of Q2 2026.
  • Jeff Yass sold 398,480 Microbot Medical shares in Q2 2026, an estimated $812K.
  • Microbot Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8134 holding.
  • Jeff Yass first reported a position in Microbot Medical in Q3 2014 and has held it in 11 quarters since.
  • Jeff Yass's Microbot Medical position peaked at $3.81M in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.